期刊文献+

从半合成噬菌体抗体库中克隆抗地高辛人单链抗体 被引量:3

Cloning of human ScFv against digoxin from a semi-synthetic phage antibody library
下载PDF
导出
摘要 目的 :从半合成噬菌体抗体库中克隆抗地高辛 (Dig)人单链抗体 (ADAScFv) ,为Dig中毒的诊断和治疗提供人源性抗体。方法 :①以改良法制备Dig BSA偶联物 ;②以固相化的Dig BSA偶联物对人噬菌体ScFv抗体库进行了 4轮筛选 ,通过ELISA筛选出能结合Dig的抗体克隆并鉴定其活性 ,通过ELISA竞争抑制实验分析其特异性 ,对阳性克隆的DNA进行测序分析。结果 :①在对抗体库的筛选过程中可见有明显的富集 ;②获得一株可结合Dig及其类似物的阳性克隆 ;③阳性克隆的可变区分别属于VH5和Vλ1亚群。结论 :利用噬菌体抗体库技术获得了能与Dig及其它洋地黄类药物结合的人ADAScFv ,经进一步分析及抗体工程改造后 ,有可能为临床上诊断及治疗洋地黄类药物中毒提供具有实用价值的人源性抗体。 Objective:To clone human anti digoxin ScFv from a human semi synthetic phage antibody library.Methods:①Digoxin BSA conjugate(Dig BSA) was preparaed by a modified periodate oxidation method.②A semi synthetic phage antibody library was panned against immobilized Dig BSA.Collected clones were analysed by ELISA,inhibition ELISA and DNA Sequencing.Results:①During the four rounds panning against Dig BSA,the enrichment of the eluted phage particles was observed;②Analysis of the eluted clones identified one clone that could bind Dig as well as other digitalis.③Sequencing analysis showed that the variable genes of the positive clone belonged to VH5 and Vλ1 subgroup respectively.Conclusion:Human Dig specific ScFv that could bind Dig and other digitalis has been cloned from a semi synthetic phage antibody library which may provide a potential reagent for the diagnosis and therapy of Dig toxication.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2001年第11期575-578,共4页 Chinese Journal of Immunology
基金 全军"九五"医药卫生科研基金项目 ( 98M14 5 ) 重点项目( 96Z0 0 4)资助
关键词 噬菌体抗体库 人单链抗体 地高辛中毒 克隆 Phage antibody library Human ScFv Digoxin Toxication
  • 相关文献

参考文献2

共引文献9

同被引文献23

  • 1刘德新,李小鹰,陈瑞晗,郝好杰,王琰.人抗地高辛单链抗体在大肠杆菌的表达[J].中国分子心脏病学杂志,2002,2(2):72-74. 被引量:1
  • 2[1]Azzazy HM, Duh SH, Maturen A, et al. Multicenter study of Abbott AxSYM Digoxin Ⅱ assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors.Clin Chem, 1997,43:1635-1640
  • 3[2]Datta P, Dasgupta A. Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity. Ther Drug Monit 1998 ;20:352-357
  • 4[3]Bowden CA and Krenzelok EP. Clinical appliccations of commonly used contemporary antidotes. Drug Saf 1997; 16: 9-47
  • 5[4]Winter G, Griffith AD, Hawkins RE, et al. Making antibodies by phage display technology. Annu Rev Immuno 1994;12:433-455
  • 6[6]Liu De-xin, Li Xiao-ying,Wang Yan. Cloning of human ScFv against digoxin from a human phage display antibody library. J Mol Cellu Cardiol,2001,33(6) :A28
  • 7[9]Short MK,Jeffrey PD, Kwong RF, et al. Contribution of Antibody Heavy Chain CDR1 to Digoxin Binding Analyzed by Random Mutagenesis of Phaged-dispayed Fab 26-10. J Biol Chem 1995 ;270:28541-28550
  • 8Liu De-xin,Li Xiao-ying,Wang Yan .Cloning of human ScFv against digoxin from a human phage display antibody library[J].J Mol Cellu Cardiol,2001,33(6):A28 .
  • 9JM.沃克,R.拉普勒,编;谭天伟,黄留云,苏国富,等译.分子生物学与生物技术[M].北京:化学工业出版社,2003.1
  • 10Wormstone IM,TamivaS,Anderson I,et al.TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag[J].Invest Ophthalmol Vis Sci,2002,43(7):2301

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部